The importance of distinct metabolites of N-nitrosodiethylamine for its in vivo mutagenic specificity.
Although N-nitrosodiethylamine (NDEA) is a potent carcinogen in rodents and a probable human carcinogen, little attempts were made to characterize its mutation spectrum in higher eukaryotes. We have compared forward mutation frequencies at multiple (700) loci with the mutational spectrum induced at the vermilion gene of Drosophila, after exposure of post- and pre-meiotic male germ cells to NDEA. Among 30 vermilion mutants collected from post-meiotic stages were 12 G:C-->A:T transitions (40%), 8 A:T-->T:A transversions (27%), and 4 structural rearrangements (13%). The remainder were three A:T-->G:C transitions, two G:C-->C:G transversions and one G:C-->T:A transversion. The results show that although NDEA induces predominantly transitions (40% G:C-->A:T and 10% A:T-->G:C), the frequencies of transversions (37%, of which 27% of A:T-->T:A transversions) and especially of rearrangements (13%) are remarkably high. This mutation spectrum differs significantly from that produced by the direct-ethylating agent N-ethylnitrosourea (ENU), although the relative distribution of ethylated DNA adducts is similar for both carcinogens. These differences, in particular the occurrence of rearrangements, are most likely the result of the requirement of NDEA for bioactivation. Since all four rearrangements were collected from non-metabolizing spermatozoa (or late spermatids), it is hypothesized that they derived from acetaldehyde, a stable metabolite of NDEA. Due to its cytotoxicity, attempts to isolate vermilion mutants from NDEA-exposed pre-meiotic cells were largely unsuccessful, because only two mutants (one A:T-->G:C transition and one 1bp insertion) were collected from those stages. Our results show that NDEA is capable of generating carcinogenic lesions other than base pair substitutions.
Sierra
L M
LM
Departamento Biología Funcional e Instituto Universitario de Oncología, Area de Genética, University of Oviedo, 33006, Oviedo, Spain. lmsierra@correo.uniovi.es
Tosal
L
L
Nivard
M J
MJ
Comendador
M A
MA
Vogel
E W
EW
D000818:Animals; D001483:Base Sequence; D002273:Carcinogens / Q000378:metabolism / Q000633:toxicity; D004252:DNA Mutational Analysis; D017931:DNA Primers / Q000235:genetics; D004052:Diethylnitrosamine / Q000378:metabolism* / Q000633:toxicity*; D004330:Drosophila / Q000187:drug effects / Q000235:genetics; D029721:Drosophila Proteins; D005136:Eye Proteins; D017344:Genes, Insect / Q000187:drug effects; D006801:Humans; D019476:Insect Proteins / Q000235:genetics; D008297:Male; D008540:Meiosis / Q000235:genetics; D009152:Mutagenicity Tests; D009153:Mutagens / Q000378:metabolism* / Q000633:toxicity*; D013091:Spermatogenesis / Q000235:genetics; D013094:Spermatozoa / Q000187:drug effects / Q000378:metabolism; D014366:Tryptophan Oxygenase
D002273:Carcinogens; D017931:DNA Primers; D029721:Drosophila Proteins; D005136:Eye Proteins; D019476:Insect Proteins; D009153:Mutagens; D004052:Diethylnitrosamine; D014366:Tryptophan Oxygenase; C121974:v protein, Drosophila